Sequencing Throughout Leukemia Treatment Unveils Therapy-Induced Changes in Mutational Profile | GenomeWeb

By Monica Heger

Whole-genome sequencing followed by ultra-deep targeted resequencing of B-cell chronic lymphocytic leukemia tumors throughout the course of treatment shows how patients' mutational profiles change in response to treatment and disease progression, according to an ongoing study.

Anna Schuh, a hematologist at the University of Oxford, reported preliminary results from the study at last week's Biology of Genomes meeting in Cold Spring Harbor, NY.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.